BIOMAT Database Logo BIOMAT Database Logo

[Antithrombin III levels in patients with acute thromboembolism during treatment with heparin]. 1986

P Barja, and M V Araya, and M Hassi

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D005260 Female Females
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

P Barja, and M V Araya, and M Hassi
Antithrombin III levels during heparin therapy.
January 1981, Thrombosis research,
P Barja, and M V Araya, and M Hassi
[Changes in antithrombin III during treatment with heparin].
January 1978, La Nouvelle presse medicale,
P Barja, and M V Araya, and M Hassi
[Antithrombin-III levels in patients with acute cerebrovascular disease].
February 1988, Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry,
P Barja, and M V Araya, and M Hassi
[Prevention of venous thromboembolism with heparin in risk patients during pregnancy: monitoring by measuring thrombin-antithrombin III complex].
December 1992, Therapeutische Umschau. Revue therapeutique,
P Barja, and M V Araya, and M Hassi
Antithrombin III in patients with acute deep vein thrombosis during heparin treatment (subcutaneous and intravenous) and during and after treatment with oral coumarins.
May 1984, Thrombosis research,
P Barja, and M V Araya, and M Hassi
Heparin and antithrombin III levels during cardiopulmonary bypass: correlation with subclinical plasma coagulation.
September 1994, The Annals of thoracic surgery,
P Barja, and M V Araya, and M Hassi
Treatment of venous thromboembolism in patients with congenital deficiency of antithrombin III.
December 1992, Thrombosis and haemostasis,
P Barja, and M V Araya, and M Hassi
[Plasma antithrombin III activity in patients with pulmonary thromboembolism].
January 1992, Polski tygodnik lekarski (Warsaw, Poland : 1960),
P Barja, and M V Araya, and M Hassi
[Thrombosis patients with familial antithrombin-III deficiency treated with heparin and antithrombin].
January 1981, Ugeskrift for laeger,
P Barja, and M V Araya, and M Hassi
Antithrombin III levels in acute leukemia.
February 1985, Blood,
Copied contents to your clipboard!